BioVie
BIVI
BioVie (BIVI) earnings history
Most recent quarter
- Fiscal period
- Q3 2025
- Period end
- Mar 31, 2025
- EPS actual
- −$1.51
- EPS estimate
- −$1.50
- EPS surprise
- −0.67%
- Revenue surprise
- +0.00%
- Revenue
- $0.00
- Revenue estimate
- $0.00
- Reported
- May 12, 2025
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q3 2025 | May 12, 2025 | −$1.50 | −$1.51 | −0.67% | $0.00 | SEC |
| Q2 2025 | Feb 11, 2025 | −$16.00 | −$4.60 | +71.25% | $0.00 | SEC |
| Q3 2024 | May 14, 2024 | −$29.00 | −$20.00 | +31.03% | $0.00 | SEC |
| Q1 2024 | Nov 8, 2023 | −$29.00 | −$29.15 | −0.52% | $0.00 | SEC |
| Q2 2023 | Feb 10, 2023 | −$29.83 | −$50.17 | −68.16% | $0.00 | SEC |
| Q1 2023 | Nov 4, 2022 | −$28.50 | −$38.00 | −33.33% | $0.00 | — |
| Q4 2022 | Sep 27, 2022 | −$40.00 | −$32.00 | +20.00% | $0.00 | — |
| Q3 2022 | May 11, 2022 | −$42.33 | −$28.00 | +33.86% | $0.00 | — |
Quarterly revenue
Frequently asked questions
When did BioVie (BIVI) last report earnings?
BioVie last reported on May 12, 2025, covering fiscal Q3 2025.
Did BIVI beat earnings estimates?
No. BioVie reported EPS of −$1.51 for Q3 2025 against a −$1.50 estimate — a 0.67% miss.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.